Divergence between serum creatine and cystatin C in estimating glomerular filtration rate of critically ill COVID-19 patients

References

• World Health Organization: Coronavirus disease (COVID-19) pandemic. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
   Google Scholar
• Asgharpour M, Zare E, Mubarak M, et al. COVID-19 and kidney disease: update on epidemiology, clinical manifestations, pathophysiology and management. J Coll Physicians Surg Pak. 2020;30(6):19–25.
   PubMed Web of Science ®Google Scholar
• Chan L, Chaudhary K, Saha A, et al. AKI in Hospitalized Patients with COVID-19. J Am Soc Nephrol. 2021;32(1):151–160.
   Google Scholar
• Hirsch JS, Ng JH, Ross DW, Northwell Nephrology COVID-19 Research Consortium, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98(1):209–218.
   PubMed Web of Science ®Google Scholar
• Farouk SS, Fiaccadori E, Cravedi P, et al. COVID-19 and the kidney: what we think we know so far and what we don't. J Nephrol. 2020;33(6):1213–1218.
   PubMed Web of Science ®Google Scholar
• Xia P, Wen Y, Duan Y, et al. Clinicopathological features and outcomes of acute kidney injury in critically ill COVID-19 with prolonged disease course: a retrospective cohort. J Am Soc Nephrol. 2020;31(9):2205–2221.
   PubMed Web of Science ®Google Scholar
• Xu J, Yang X, Yang L, et al. Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China. Crit Care. 2020;24(1):394.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–838.
   PubMed Web of Science ®Google Scholar
• Pei G, Zhang Z, Peng J, et al. Renal involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol. 2020;31(6):1157–1165.
   PubMed Web of Science ®Google Scholar
• Steinke T, Moritz S, Beck S, et al. Estimation of creatinine clearance using plasma creatinine or cystatin C: a secondary analysis of two pharmacokinetic studies in surgical ICU patients. BMC Anesthesiol. 2015;15(1):62.
   PubMedGoogle Scholar
• Sangla F, Marti PE, Verissimo T, et al. Measured and estimated glomerular filtration rate in the ICU: a prospective study. Crit Care Med. 2020;48(12):e1232–e1241.
   PubMed Web of Science ®Google Scholar
• Thongprayoon C, Cheungpasitporn W, Kashani K. Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients. J Thorac Dis. 2016;8(5):E305–11.
   PubMed Web of Science ®Google Scholar
• Seller-Perez G, Herrera-Gutierrez ME, Maynar-Moliner J, et al. Estimating kidney function in the critically ill patients. Crit Care Res Pract. 2013;2013:721810.
   PubMedGoogle Scholar
• Baptista JP, Udy AA, Sousa E, et al. A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance. Crit Care. 2011;15(3):R139.
   PubMed Web of Science ®Google Scholar
• Baptista JP, Neves M, Rodrigues L, et al. Accuracy of the estimation of glomerular filtration rate within a population of critically ill patients. J Nephrol. 2014;27(4):403–410.
   PubMed Web of Science ®Google Scholar
• Patel SS, Molnar MZ, Tayek JA, et al. Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. J Cachexia Sarcopenia Muscle. 2013;4(1):19–29.
   PubMed Web of Science ®Google Scholar
• Udy AA, Baptista JP, Lim NL, et al. Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations. Crit Care Med. 2014;42(3):520–527.
   PubMed Web of Science ®Google Scholar
• Hoste EA, Damen J, Vanholder RC, et al. Assessment of renal function in recently admitted critically ill patients with normal serum creatinine. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association. Eur Renal Assoc. 2005;20(4):747–753.
   Google Scholar
• Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. 2009;75(6):652–660.
   PubMed Web of Science ®Google Scholar
• Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004;65(4):1416–1421.
   PubMed Web of Science ®Google Scholar
• Zhai JL, Ge N, Zhen Y, et al. Corticosteroids significantly increase serum cystatin C concentration without affecting renal function in symptomatic heart failure. Clin Lab. 2016;62(01 + 02/2016):203–207.
   PubMedGoogle Scholar
• Ying P, Yang C, Wu X, et al. Effect of hydrocortisone on the 28-day mortality of patients with septic acute kidney injury. Ren Fail. 2019;41(1):794–799.
   PubMed Web of Science ®Google Scholar
• Tsushita H, Tanaka R, Suzuki Y, et al. Effects of dose and type of corticosteroids on the divergence between estimated glomerular filtration rates derived from cystatin C and creatinine. J Clin Pharm Ther. 2020;45(6):1390–1397.
   PubMed Web of Science ®Google Scholar
• Muslimovic A, Tulumovic D, Hasanspahic S, et al. Serum cystatin C - marker of inflammation and cardiovascular morbidity in chronic kidney disease stages 1-4. Mater Sociomed. 2015;27(2):75.
   PubMedGoogle Scholar
• Borges RL, Hirota AH, Quinto BM, et al. Is cystatin C a useful marker in the detection of diabetic kidney disease? Nephron Clin Pract. 2010;114(2):c127–34.
   PubMedGoogle Scholar
• Deng Y, Wang L, Hou Y, et al. The influence of glycemic status on the performance of cystatin C for acute kidney injury detection in the critically ill. Ren Fail. 2019;41(1):139–149.
   PubMed Web of Science ®Google Scholar
• National Health Commission of China: Guideline of management of COVID-19 (5th trial edition). Available at: http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440.shtml
   Google Scholar
• Shankar-Hari M, Phillips GS, Levy ML, for the Sepsis Definitions Task Force, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):775–787.
   PubMed Web of Science ®Google Scholar
• Rubin S, Orieux A, Prevel R, et al. Characterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019. Clin Kidney J. 2020;13(3):354–361.
   PubMed Web of Science ®Google Scholar
• Bragadottir G, Redfors B, Ricksten SE. Assessing glomerular filtration rate (GFR) in critically ill patients with acute kidney injury-true GFR versus urinary creatinine clearance and estimating equations. Crit Care. 2013;17(3):R108.
   PubMed Web of Science ®Google Scholar
• Joskova V, Patkova A, Havel E, et al. Critical evaluation of muscle mass loss as a prognostic marker of morbidity in critically ill patients and methods for its determination. J Rehabil Med. 2018;50(8):696–704.
   PubMed Web of Science ®Google Scholar
• Carlier M, Dumoulin A, Janssen A, et al. Comparison of different equations to assess glomerular filtration in critically ill patients. Intensive Care Med. 2015;41(3):427–435.
   PubMed Web of Science ®Google Scholar
• Royakkers AA, Korevaar JC, van Suijlen JD, et al. Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. Intensive Care Med. 2011;37(3):493–501.
   PubMed Web of Science ®Google Scholar
• Hamed HM, El-Sherbini SA, Barakat NA, et al. Serum cystatin C is a poor biomarker for diagnosing acute kidney injury in critically-ill children. Indian J Crit Care Med. 2013;17(2):92–98.
   PubMedGoogle Scholar
• Ravn B, Rimes-Stigare C, Bell M, et al. Creatinine versus cystatin C based glomerular filtration rate in critically ill patients. J Crit Care. 2019;52:136–140.
   PubMed Web of Science ®Google Scholar
• Ravn B, Prowle JR, Martensson J, et al. Superiority of serum cystatin C over creatinine in prediction of long-term prognosis at discharge from ICU. Crit Care Med. 2017;45(9):e932–e940.
   PubMed Web of Science ®Google Scholar
• Zhang M, Li Y, Yang X, et al. Serum cystatin C as an inflammatory marker in exacerbated and convalescent COPD patients. Inflammation. 2016;39(2):625–631.
   PubMed Web of Science ®Google Scholar
• Chen D, Sun W, Li J, et al. Serum cystatin C and coronavirus disease 2019: a potential inflammatory biomarker in predicting critical illness and mortality for adult patients. Mediat Inflamm. 2020;2020:1–10.
   Web of Science ®Google Scholar
• Risch L, Herklotz R, Blumberg A, et al. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem. 2001;47(11):2055–2059.
   PubMed Web of Science ®Google Scholar
• Herget-Rosenthal S, Marggraf G, Hüsing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004;66(3):1115–1122.
   PubMed Web of Science ®Google Scholar
• Liosis S, Hochadel M, Darius H, et al. Effect of renal insufficiency and diabetes mellitus on in-hospital mortality after acute coronary syndromes treated with primary PCI. Results from the ALKK PCI Registry. Int J Cardiol. 2019;292:43–49.
   PubMed Web of Science ®Google Scholar
• Cooper WA, O’Brien SM, Thourani VH, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation. 2006;113(8):1063–1070.
   PubMed Web of Science ®Google Scholar
• Hailpern SM, Cohen HW, Alderman MH. Renal dysfunction and ischemic heart disease mortality in a hypertensive population. J Hypertens. 2005;23(10):1809–1816.
   PubMed Web of Science ®Google Scholar
• Figliozzi S, Masci PG, Ahmadi N, et al. Predictors of adverse prognosis in COVID-19: a systematic review and meta-analysis. Eur J Clin Invest. 2020;50(10):e13362.
   PubMed Web of Science ®Google Scholar
• Li Y, Yang S, Peng D, et al. Predictive value of serum cystatin C for risk of mortality in severe and critically ill patients with COVID-19. WJCC. 2020;8(20):4726–4734.
   PubMed Web of Science ®Google Scholar
• Dalcomune DM, Terrao J, Porto ML, et al. Predictive value of cystatin C for the identification of illness severity in adult patients in a mixed intensive care unit. Clin Biochem. 2016;49(10-11):762–767.
   PubMed Web of Science ®Google Scholar
• Chen L, Liu HG, Liu W, et al. Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. J Tubercul Respir Dis. 2020;43:E005.
   Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet. 2020;395(10229):1033–1034.
   PubMed Web of Science ®Google Scholar
• Brigham KL. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Curr Infect Dis Rep. 2005;7(5):327–328.
   PubMedGoogle Scholar
• Wang H, Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med. 2008;26(6):711–715.
   PubMed Web of Science ®Google Scholar